Skip to main content
SpringerLink
Log in

Cutaneous Cryoglobulinemic Vasculitis

  • Chapter
  • First Online:
HCV Infection and Cryoglobulinemia

Abstract

The Chapel Hill Consensus Conference criteria define cryoglobulinemic vasculitis (CV) as “vasculitis, with cryoglobulin immune deposits, affecting small vessels (i.e. capillaries, venules, or arterioles), and associated with cryoglobulins in the serum.” Hepatitis C virus (HCV) infection is the underlying etiologic factor in the majority of cases of CV, but it also occurs secondary to other infections (e.g., hepatitis B), connective tissue diseases (e.g., Sjögren’s syndrome), and hematolymphoid proliferations (e.g., Waldenström’s macroglobulinemia). Purpura, arthralgia, and weakness are the most common presenting signs and symptoms but any organ can be affected (skin, kidney, and nerves most frequently). The extent of involvement and disease severity progress with time in the absence of treatment. Recurrent palpable purpura associated with post-inflammatory hyperpigmenation is the most frequent cutaneous manifestation of CV but others include nodules, leg ulcers, livedo racemosa, and digital gangrene, i.e., signs of muscular-vessel vasculitis. Skin biopsy shows a small-vessel neutrophilic vasculitis equally affecting superficial and deep dermal and subcutis vessels, with neutrophilic muscular-vessel vasculitis in a minority of cases. Thrombosis, in some instances by hyaline/ type I cryoglobulin thrombi, contributes to the ischemic damage. By direct immunofluorescence, abundant IgM, and complement deposits are found in the affected vessels, highlighting the immune-complex mediated pathogenesis. Adverse prognostic factors for HCV-related CV include the presence of ulcers and renal insufficiency. Anti-HCV therapy (interferon-α and ribavirin) with or without rituximab is associated with a favorable clinical response, but relapse is common. In some patients, the persistent CV necessitates the administration of immunosuppressive agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Meltzer M, Franklin EC, Elias K et al (1966) Cryoglo­bulinemia – a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 40(6):837–856

    Article  PubMed  CAS  Google Scholar 

  2. Cacoub P, Costedoat-Chalumeau N, Lidove O, Alric L (2002) Cryoglobulinemia vasculitis. Curr Opin Rheumatol 14(1):29–35

    Article  PubMed  CAS  Google Scholar 

  3. Ferri C, Zignego AL, Giuggioli D et al (2002) HCV and cryoglobulinemic vasculitis. Cleve Clin J Med 69(Suppl 2):SII20–SII23

    Article  PubMed  Google Scholar 

  4. Gorevic PD, Kassab HJ, Levo Y et al (1980) Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69(2):287–308

    Article  PubMed  CAS  Google Scholar 

  5. Sansonno D, Dammacco F (2005) Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis 5(4):227–236

    Article  PubMed  Google Scholar 

  6. Brouet JC, Clauvel JP, Danon F et al (1974) Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57(5):775–788

    Article  PubMed  CAS  Google Scholar 

  7. Tedeschi A, Barate C, Minola E, Morra E (2007) Cryoglobulinemia. Blood Rev 21(4):183–200

    Article  PubMed  CAS  Google Scholar 

  8. Cacoub P, Saadoun D (2008) Hepatitis C virus infection induced vasculitis. Clin Rev Allergy Immunol 35(1–2):30–39

    Article  PubMed  CAS  Google Scholar 

  9. Carlson JA, Ng BT, Chen KR (2005) Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol 27(6):504–528

    Article  PubMed  Google Scholar 

  10. Jennette JC, Falk RJ (2000) Overview of the nomenclature and diagnostic categorization of vasculitis. Wien Klin Wochenschr 112(15–16):650–655

    PubMed  CAS  Google Scholar 

  11. Gungor E, Cirit A, Alli N et al (1999) Prevalence of hepatitis C virus antibodies and cryoglobulinemia in patients with leukocytoclastic vasculitis. Dermatology 198(1):26–28

    Article  PubMed  CAS  Google Scholar 

  12. Sais G, Vidaller A, Jucgla A et al (1998) Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol 134(3):309–315

    Article  PubMed  CAS  Google Scholar 

  13. Gonzalez-Gay MA, Garcia-Porrua C (1999) Systemic vasculitis in adults in northwestern Spain, 1988–1997. Clinical and epidemiologic aspects. Medicine (Baltimore) 78(5):292–308

    Article  CAS  Google Scholar 

  14. Ferri C (2008) Mixed cryoglobulinemia. Orphanet J Rare Dis 3:25

    Article  PubMed  Google Scholar 

  15. Herrine SK (2002) Approach to the patient with chronic hepatitis C virus infection. Ann Intern Med 136(10):747–757

    Article  PubMed  Google Scholar 

  16. Dispenzieri A, Gorevic PD (1999) Cryoglobulinemia. Hematol Oncol Clin North Am 13(6):1315–1349

    Article  PubMed  CAS  Google Scholar 

  17. Lamprecht P, Gause A, Gross WL (1999) Cryoglobulinemic vasculitis. Arthritis Rheum 42(12):2507–2516

    Article  PubMed  CAS  Google Scholar 

  18. Braun GS, Horster S, Wagner K et al (2007) Cryoglo­bulinaemic vasculitis: classification and clinical and therapeutic aspects. Postgrad Med J 83(976):87–94

    Article  PubMed  Google Scholar 

  19. Gumber SC, Chopra S (1995) Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 123(8):615–620

    Article  PubMed  CAS  Google Scholar 

  20. Bombardieri S, Ferri C, Migliorini P et al (1986) Cryoglobulins and immune complexes in essential mixed cryoglobulinemia. Ric Clin Lab 16(2):281–288

    PubMed  CAS  Google Scholar 

  21. Levo Y, Gorevic PD, Kassab HJ et al (1977) Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 296(26):1501–1504

    Article  PubMed  CAS  Google Scholar 

  22. Pascual M, Perrin L, Giostra E, Schifferli JA (1990) Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 162(2):569–570

    Article  PubMed  CAS  Google Scholar 

  23. Abel G, Zhang QX, Agnello V (1993) Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 36(10):1341–1349

    Article  PubMed  CAS  Google Scholar 

  24. Monti G, Galli M, Invernizzi F et al (1995) Cryoglo­bulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian group for the study of cryoglobulinaemias. QJM 88(2):115–126

    PubMed  CAS  Google Scholar 

  25. Ferri C, Sebastiani M, Giuggioli D et al (2004) Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33(6):355–374

    Article  PubMed  Google Scholar 

  26. Ferri C, La Civita L, Longombardo G et al (1993) Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest 23(7):399–405

    Article  PubMed  CAS  Google Scholar 

  27. Monti G, Pioltelli P, Saccardo F et al (2005) Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 165(1):101–105

    Article  PubMed  Google Scholar 

  28. Ramos-Casals M, Munoz S, Medina F et al (2009) Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (the HISPAMEC registry). J Rheumatol 36(7):1442–1448

    Article  PubMed  Google Scholar 

  29. Santagostino E, Colombo M, Cultraro D et al (1998) High prevalence of serum cryoglobulins in multitransfused hemophilic patients with chronic hepatitis C. Blood 92(2):516–519

    PubMed  CAS  Google Scholar 

  30. Lunel F, Musset L, Cacoub P et al (1994) Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106(5):1291–1300

    PubMed  CAS  Google Scholar 

  31. Pawlotsky JM, Ben Yahia M, Andre C et al (1994) Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 19(4):841–848

    Article  PubMed  CAS  Google Scholar 

  32. Ramos-Casals M, Font J (2005) Extrahepatic manifestations in patients with chronic hepatitis C virus infection. Curr Opin Rheumatol 17(4):447–455

    PubMed  Google Scholar 

  33. Agnello V (1998) Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity. Ann Rheum Dis 57(12):701–702

    Article  PubMed  CAS  Google Scholar 

  34. Ferri C, Mascia MT (2006) Cryoglobulinemic vasculitis. Curr Opin Rheumatol 18(1):54–63

    PubMed  Google Scholar 

  35. Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN (2002) Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 36(4 Pt 1):978–985

    PubMed  Google Scholar 

  36. Karlsberg PL, Lee WM, Casey DL et al (1995) Cutaneous vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus-induced mixed cryoglobulinemia. Arch Dermatol 131(10):1119–1123

    Article  PubMed  CAS  Google Scholar 

  37. Levey JM, Bjornsson B, Banner B et al (1994) Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literature. Medicine (Baltimore) 73(1):53–67

    CAS  Google Scholar 

  38. Cacoub P, Poynard T, Ghillani P et al (1999) Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC group. Multidepartment virus C. Arthritis Rheum 42(10):2204–2212

    Article  PubMed  CAS  Google Scholar 

  39. Vallat L, Benhamou Y, Gutierrez M et al (2004) Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection. Arthritis Rheum 50(11):3668–3678

    Article  PubMed  Google Scholar 

  40. Sansonno D, De Vita S, Iacobelli AR et al (1998) Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 160(7):3594–3601

    PubMed  CAS  Google Scholar 

  41. Racanelli V, Sansonno D, Piccoli C et al (2001) Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol 167(1):21–29

    PubMed  CAS  Google Scholar 

  42. Berliner S, Weinberger A, Ben-Bassat M et al (1982) Small skin blood vessel occlusions by cryoglobulin aggregates in ulcerative lesions in IgM-IgG cryoglobulinemia. J Cutan Pathol 9(2):96–103

    Article  PubMed  CAS  Google Scholar 

  43. Feiner HD (1983) Relationship of tissue deposits of cryoglobulin to clinical features of mixed cryoglobulinemia. Hum Pathol 14(8):710–715

    Article  PubMed  CAS  Google Scholar 

  44. Szymanski IO, Pullman JM, Underwood JM (1994) Electron microscopic and immunochemical studies in a patient with hepatitis C virus infection and mixed cryoglobulinemia type II. Am J Clin Pathol 102(3):278–283

    PubMed  CAS  Google Scholar 

  45. Agnello V, Abel G (1997) Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 40(11):2007–2015

    Article  PubMed  CAS  Google Scholar 

  46. Bernacchi E, Civita LL, Caproni M et al (1999) Hepatitis C virus (HCV) in cryoglobulinaemic leukocytoclastic vasculitis (LCV): could the presence of HCV in skin lesions be related to T CD8+ lymphocytes, HLA-DR and ICAM-1 expression? Exp Dermatol 8(6):480–486

    Article  PubMed  CAS  Google Scholar 

  47. Sansonno D, Cornacchiulo V, Iacobelli AR et al (1995) Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 21(2):305–312

    PubMed  CAS  Google Scholar 

  48. Wei G, Yano S, Kuroiwa T et al (1997) Hepatitis C virus (HCV)-induced IgG-IgM rheumatoid factor (RF) complex may be the main causal factor for cold-dependent activation of complement in patients with rheumatic disease. Clin Exp Immunol 107(1):83–88

    Article  PubMed  CAS  Google Scholar 

  49. Levine JW, Gota C, Fessler BJ et al (2005) Persistent cryoglobulinemic vasculitis following successful treatment of hepatitis C virus. J Rheumatol 32(6):1164–1167

    PubMed  Google Scholar 

  50. Landau DA, Saadoun D, Halfon P et al (2008) Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheum 58(2):604–611

    Article  PubMed  Google Scholar 

  51. Chan LS, Vanderlugt CJ, Hashimoto T et al (1998) Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 110(2):103–109

    Article  PubMed  CAS  Google Scholar 

  52. Dupin N, Chosidow O, Lunel F et al (1995) Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus [see comments]. Arch Dermatol 131(10):1124–1127

    Article  PubMed  CAS  Google Scholar 

  53. Cattaneo R, Fenini MG, Facchetti F (1986) The cryoglobulinemic vasculitis. Ric Clin Lab 16(2):327–333

    PubMed  CAS  Google Scholar 

  54. Buezo GF, Garcia-Buey M, Rios-Buceta L et al (1996) Cryoglobulinemia and cutaneous leukocytoclastic vasculitis with hepatitis C virus infection. Int J Dermatol 35(2):112–115

    Article  PubMed  CAS  Google Scholar 

  55. Auzerie V, Chiali A, Bussel A et al (2003) Leg ulcers associated with cryoglobulinemia: clinical study of 15 patients and response to treatment. Arch Dermatol 139(3):391–393

    Article  PubMed  Google Scholar 

  56. Krunic AL, Medenica MM, Laumann AE, Shaw JC (2003) Cryoglobulinaemic vasculitis, cryofibrinogenaemia and low-grade B-cell lymphoma. Br J Dermatol 148(5):1079–1081

    Article  PubMed  CAS  Google Scholar 

  57. Baughman RD, Sommer RG (1966) Cryoglobulinemia ­presenting as “factitial ulceration”. Arch Dermatol 94(6): 725–731

    Article  PubMed  CAS  Google Scholar 

  58. Ellis FA (1964) The cutaneous manifestation of cryoglobulinemia. Arch Dermatol 89:690–697

    Article  PubMed  CAS  Google Scholar 

  59. Harper JI, Gray W, Wilson-Jones E (1983) Cryoglobulinaemia and angiomatosis. Br J Dermatol 109(4):453–458

    Article  PubMed  CAS  Google Scholar 

  60. Resnik KS (2009) Intravascular eosinophilic deposits-when common knowledge is insufficient to render a diagnosis. Am J Dermatopathol 31(3):211–217

    PubMed  Google Scholar 

  61. Cohen SJ, Pittelkow MR, Su WP (1991) Cutaneous manifestations of cryoglobulinemia: clinical and histopathologic study of seventy-two patients. J Am Acad Dermatol 25(1 Pt 1):21–27

    Article  PubMed  CAS  Google Scholar 

  62. Buchsbaum M, Werth V (1994) Erythema nodosum-like nodules associated with vasculitis resulting from mixed cryoglobulinemia. J Am Acad Dermatol 31(3 Pt 1): 493–495

    Article  PubMed  CAS  Google Scholar 

  63. Boom BW, Brand A, Bavinck JN et al (1988) Severe leukocytoclastic vasculitis of the skin in a patient with essential mixed cryoglobulinemia treated with high-dose gamma-globulin intravenously. Arch Dermatol 124(10):1550–1553

    Article  PubMed  CAS  Google Scholar 

  64. Mekkes JR, Loots MA, van der Wal AC, Bos JD (2004) Increased incidence of hypercoagulability in patients with leg ulcers caused by leukocytoclastic vasculitis. J Am Acad Dermatol 50(1):104–107

    Article  PubMed  Google Scholar 

  65. Claudy A (1999) Coagulation and fibrinolysis in cutaneous vasculitis. Clin Dermatol 17(6):615–618

    Article  PubMed  CAS  Google Scholar 

  66. Tomizawa K, Sato-Matsumura KC, Kajii N (2003) The coexistence of cutaneous vasculitis and thrombosis in childhood-onset systemic lupus erythematosus with antiphospholipid antibodies. Br J Dermatol 149(2):439–441

    Article  PubMed  CAS  Google Scholar 

  67. Rocca PV, Siegel LB, Cupps TR (1994) The concomitant expression of vasculitis and coagulopathy: synergy for marked tissue ischemia. J Rheumatol 21(3):556–560

    PubMed  CAS  Google Scholar 

  68. Trejo O, Ramos-Casals M, Garcia-Carrasco M et al (2001) Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80(4):252–262

    Article  CAS  Google Scholar 

  69. Bryce AH, Kyle RA, Dispenzieri A, Gertz MA (2006) Natural history and therapy of 66 patients with mixed cryoglobulinemia. Am J Hematol 81(7):511–518

    Article  PubMed  Google Scholar 

  70. Iannuzzella F, Vaglio A, Garini G (2010) Management of hepatitis C virus-related mixed cryoglobulinemia. Am J Med 123(5):400–408

    Article  PubMed  Google Scholar 

  71. Bessis D, Dereure O, Rivire S et al (2002) Diffuse Bier white spots revealing cryoglobulinaemia. Br J Dermatol 146(5):921–922

    Article  PubMed  CAS  Google Scholar 

  72. Wager O, Mustakallio KK, Rasanen JA (1968) Mixed IgA-IgG cryoglobulinemia. Immunological studies and case reports of three patients. Am J Med 44(2):179–187

    Article  PubMed  CAS  Google Scholar 

  73. Bruchfeld A, Lindahl K, Stahle L et al (2003) Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant 18(8):1573–1580

    Article  PubMed  CAS  Google Scholar 

  74. Nir MA, Pick AI, Schreibman S et al (1974) Mixed IgG-IgM cryoglobulinemia with follicular pustular purpura. Arch Dermatol 109(4):539–542

    Article  PubMed  CAS  Google Scholar 

  75. Crowson AN, Nuovo G, Ferri C, Magro CM (2003) The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases. Hum Pathol 34(6):573–579

    Article  PubMed  Google Scholar 

  76. Abajo P, Porras-Luque JI, Buezo GF et al (1998) Red finger syndrome associated with necrotizing vasculitis in an HIV-infected patient with hepatitis B. Br J Dermatol 139(1):154–155

    Article  PubMed  CAS  Google Scholar 

  77. Koda H, Kanaide A, Asahi M, Urabe H (1978) Essential IgG cryoglobulinemia with purpura and cold urticaria. Arch Dermatol 114(5):784–786

    Article  PubMed  CAS  Google Scholar 

  78. Lin RY, Caren CB, Menikoff H (1995) Hypocomplementaemic urticarial vasculitis, interstitial lung disease and hepatitis C. Br J Dermatol 132(5):821–823

    Article  PubMed  CAS  Google Scholar 

  79. Erkek E, Ayaslioglu E, Erdogan S, Bagci Y (2007) Vasculopathic skin lesions following epilation, leading to a discovery of hepatitis C virus infection. Clin Exp Dermatol 32(2):221–222

    Article  PubMed  CAS  Google Scholar 

  80. Rieu V, Cohen P, Andre MH et al (2002) Characteristics and outcome of 49 patients with symptomatic cryoglobulinaemia. Rheumatology (Oxford) 41(3):290–300

    Article  CAS  Google Scholar 

  81. Genereau T, Martin A, Lortholary O et al (1998) Temporal arteritis symptoms in a patient with hepatitis C virus associated type II cryoglobulinemia and small vessel vasculitis. J Rheumatol 25(1):183–185

    PubMed  CAS  Google Scholar 

  82. Parodi A, Cozzani E, Sorbara S, Rebora A (2005) Hepatitis C virus-related cutaneous vasculitis in the absence of specific antibodies. Clin Exp Dermatol 30(2):188

    Article  PubMed  CAS  Google Scholar 

  83. Popp JW Jr, Harrist TJ, Dienstag JL et al (1981) Cutaneous vasculitis associated with acute and chronic hepatitis. Arch Intern Med 141(5):623–629

    Article  PubMed  Google Scholar 

  84. Daoud MS, El-Azhary RA, Gibson LE et al (1996) Chronic hepatitis C, cryoglobulinemia, and cutaneous necrotizing vasculitis. Clinical, pathologic, and immunopathologic study of twelve patients. J Am Acad Dermatol 34(2 Pt 1): 219–223

    Article  PubMed  CAS  Google Scholar 

  85. Landau DA, Scerra S, Sene D et al (2010) Causes and predictive factors of mortality in a cohort of patients with hepatitis C virus-related cryoglobulinemic vasculitis treated with antiviral therapy. J Rheumatol 28:2010

    Google Scholar 

  86. Pakula AS, Garden JM, Roth SI (1993) Cryoglobulinemia and cutaneous leukocytoclastic vasculitis associated with hepatitis C virus infection. J Am Acad Dermatol 28(5 Pt 2):850–853

    Article  PubMed  CAS  Google Scholar 

  87. Sepp NT, Umlauft F, Illersperger B et al (1995) Necrotizing vasculitis associated with hepatitis C virus infection: ­successful treatment of vasculitis with interferon-alpha despite persistence of mixed cryoglobulinemia. Dermatology 191(1):43–45

    Article  PubMed  CAS  Google Scholar 

  88. von Kobyletzki G, Stucker M, Hoffmann K et al (1998) Severe therapy-resistant necrotizing vasculitis associated with hepatitis C virus infection: successful treatment of the vasculitis with extracorporeal immunoadsorption. Br J Dermatol 138(4):718–719

    Article  Google Scholar 

  89. Chen KR, Carlson JA (2008) Clinical approach to cutaneous vasculitis. Am J Clin Dermatol 9(2):71–92

    Article  PubMed  Google Scholar 

  90. Carlson JA, Chen KR (2007) Cutaneous pseudovasculitis. Am J Dermatopathol 29(1):44–55

    Article  PubMed  Google Scholar 

  91. Ferri C, Mannini L, Bartoli V et al (1990) Blood viscosity and filtration abnormalities in mixed cryoglobulinemia patients. Clin Exp Rheumatol 8(3):271–281

    PubMed  CAS  Google Scholar 

  92. Monteverde A, Rivano MT, Allegra GC et al (1988) Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohisto-chemical findings in liver frozen sections. Acta Haematol 79(1):20–25

    Article  PubMed  CAS  Google Scholar 

  93. Saadoun D, Suarez F, Lefrere F et al (2005) Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 105(1):74–76

    Article  PubMed  CAS  Google Scholar 

  94. Andre M, Mahammedi H, Aumaitre O et al (2000) A “missed” cryoglobulin: the importance of in vitro calcium concentration. Ann Rheum Dis 59(6):490–492

    Article  PubMed  CAS  Google Scholar 

  95. Lamprecht P, Gutzeit O, Csernok E et al (2003) Prevalence of ANCA in mixed cryoglobulinemia and chronic hepatitis C virus infection. Clin Exp Rheumatol 21(6 Suppl 32):S89–S94

    PubMed  CAS  Google Scholar 

  96. Cacoub P, Renou C, Rosenthal E et al (2000) Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore) 79(1):47–56

    Article  CAS  Google Scholar 

  97. Ferri C, Pietrogrande M, Cecchetti R et al (1989) Low-antigen-content diet in the treatment of patients with mixed cryoglobulinemia. Am J Med 87(5):519–524

    Article  PubMed  CAS  Google Scholar 

  98. Sabry AA, Sobh MA, Sheaashaa HA et al (2002) Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy. Nephrol Dial Transplant 17(11):1924–1930

    Article  PubMed  CAS  Google Scholar 

  99. Dammacco F, Tucci FA, Lauletta G et al (2010) Pegylated interferon-alpha, ribavirin, and rituximab combined ­therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood 116(3):343–353

    Article  PubMed  CAS  Google Scholar 

  100. Roccatello D, Baldovino S, Rossi D et al (2004) Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant 19(12):3054–3061

    Article  PubMed  CAS  Google Scholar 

  101. Cacoub P, Lidove O, Maisonobe T et al (2002) Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 46(12):3317–3326

    Article  PubMed  CAS  Google Scholar 

  102. Cacoub P, Saadoun D, Limal N et al (2005) PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 52(3):911–915

    Article  PubMed  CAS  Google Scholar 

  103. Mazzaro C, Zorat F, Caizzi M et al (2005) Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol 42(5):632–638

    Article  PubMed  CAS  Google Scholar 

  104. Casato M, Lagana B, Pucillo LP, Quinti I (1998) Interferon for hepatitis C virus-negative type II mixed cryoglobulinemia. N Engl J Med 338(19):1386–1387

    Article  PubMed  CAS  Google Scholar 

  105. Monti G, Saccardo F, Rinaldi G et al (1995) Colchicine in the treatment of mixed cryoglobulinemia. Clin Exp Rheumatol 13(Suppl 13):S197–S199

    PubMed  Google Scholar 

  106. Attal N, Cruccu G, Haanpaa M et al (2006) EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 13(11):1153–1169

    Article  PubMed  CAS  Google Scholar 

  107. Ferri C, Giuggioli D, Cazzato M et al (2003) HCV-related cryoglobulinemic vasculitis: an update on its etiopathogenesis and therapeutic strategies. Clin Exp Rheumatol 21(6 Suppl 32):S78–S84

    PubMed  CAS  Google Scholar 

  108. Zaja F, De Vita S, Mazzaro C et al (2003) Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101(10):3827–3834

    Article  PubMed  CAS  Google Scholar 

  109. Sansonno D, De Re V, Lauletta G et al (2003) Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101(10):3818–3826

    Article  PubMed  CAS  Google Scholar 

  110. Cacoub P, Delluc A, Saadoun D et al (2008) Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand? Ann Rheum Dis 67(3):283–287

    Article  PubMed  CAS  Google Scholar 

  111. Bhopale GM, Nanda RK (2005) Emerging drugs for chronic hepatitis C. Hepatol Res 32(3):146–153

    Article  PubMed  CAS  Google Scholar 

  112. Ferri C, Longombardo G, La Civita L et al (1994) Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease. J Intern Med 236(1):31–36

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Albany Medical College, Albany, NY, USA

    Konstantinos Linos

  2. Dermatologique Clinique, Les Hopitaux Universtaires de Strasbourg, Strasbourg, France

    Bernard Cribier

  3. Division of Dermatology and Dermatopathology, Department of Pathology, Albany Medical College, Albany, NY, USA

    J. Andrew Carlson

Authors
  1. Konstantinos Linos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernard Cribier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Andrew Carlson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Andrew Carlson .

Editor information

Editors and Affiliations

  1. , Department of Internal Medicine and Clin, University of Bari, Piazza Giulio Cesare 11, Bari, 70124, Italy

    Franco Dammacco

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Italia

About this chapter

Cite this chapter

Linos, K., Cribier, B., Carlson, J.A. (2012). Cutaneous Cryoglobulinemic Vasculitis. In: Dammacco, F. (eds) HCV Infection and Cryoglobulinemia. Springer, Milano. https://doi.org/10.1007/978-88-470-1705-4_25

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1705-4_25

  • Published:

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1704-7

  • Online ISBN: 978-88-470-1705-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation